Report Detail
Global Nanopharmaceuticals Market Growth 2019-2024
- RnM2851434 |
- 01 February, 2019 |
- Global |
- 177 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
USA is a huge market, and the total sum of the industry is more than 8756.7 million USD in 2015. At the same time, this industry continuously increases, with the development of global economy.
USA is the largest market of nanopharmaceuticals, which occupies 60.69 percent of global nanopharmaceuticals market share in 2014. It is followed by Europe, which has around 33.37 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
The relatively-mature technology is NanoCrystalsTM, DissCubes® and Nanopure®. The carrier includes nanospheres, nanocapsules, solid lipid nanoparticles, microemulsion, nanoliposome, magnetic nanoparticles, polymeric micelles, dendrimers, and inorganic nanometer carrier.
According to this study, over the next five years the Nanopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nanopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
This study considers the Nanopharmaceuticals value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nanopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Nanopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Nanopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nanopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Nanopharmaceuticals Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nanopharmaceuticals Consumption 2014-2024
- 2.1.2 Nanopharmaceuticals Consumption CAGR by Region
- 2.2 Nanopharmaceuticals Segment by Type
- 2.2.1 Liposomes
- 2.2.2 Polymeric Micelles
- 2.2.3 Solid Lipid Nanoparticles
- 2.2.4 Microemulsion and Nnanoemulsion
- 2.2.5 Nanosuspension
- 2.3 Nanopharmaceuticals Consumption by Type
- 2.3.1 Global Nanopharmaceuticals Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Nanopharmaceuticals Sale Price by Type (2014-2019)
- 2.4 Nanopharmaceuticals Segment by Application
- 2.4.1 Cancer and Tumor
- 2.4.2 Autoimmune Disorders
- 2.4.3 Inflammation
- 2.4.4 Others
- 2.5 Nanopharmaceuticals Consumption by Application
- 2.5.1 Global Nanopharmaceuticals Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Nanopharmaceuticals Value and Market Share by Application (2014-2019)
- 2.5.3 Global Nanopharmaceuticals Sale Price by Application (2014-2019)
3 Global Nanopharmaceuticals by Players
- 3.1 Global Nanopharmaceuticals Sales Market Share by Players
- 3.1.1 Global Nanopharmaceuticals Sales by Players (2017-2019)
- 3.1.2 Global Nanopharmaceuticals Sales Market Share by Players (2017-2019)
- 3.2 Global Nanopharmaceuticals Revenue Market Share by Players
- 3.2.1 Global Nanopharmaceuticals Revenue by Players (2017-2019)
- 3.2.2 Global Nanopharmaceuticals Revenue Market Share by Players (2017-2019)
- 3.3 Global Nanopharmaceuticals Sale Price by Players
- 3.4 Global Nanopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Nanopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Nanopharmaceuticals Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Nanopharmaceuticals by Regions
- 4.1 Nanopharmaceuticals by Regions
- 4.1.1 Global Nanopharmaceuticals Consumption by Regions
- 4.1.2 Global Nanopharmaceuticals Value by Regions
- 4.2 Americas Nanopharmaceuticals Consumption Growth
- 4.3 APAC Nanopharmaceuticals Consumption Growth
- 4.4 Europe Nanopharmaceuticals Consumption Growth
- 4.5 Middle East & Africa Nanopharmaceuticals Consumption Growth
5 Americas
- 5.1 Americas Nanopharmaceuticals Consumption by Countries
- 5.1.1 Americas Nanopharmaceuticals Consumption by Countries (2014-2019)
- 5.1.2 Americas Nanopharmaceuticals Value by Countries (2014-2019)
- 5.2 Americas Nanopharmaceuticals Consumption by Type
- 5.3 Americas Nanopharmaceuticals Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Nanopharmaceuticals Consumption by Countries
- 6.1.1 APAC Nanopharmaceuticals Consumption by Countries (2014-2019)
- 6.1.2 APAC Nanopharmaceuticals Value by Countries (2014-2019)
- 6.2 APAC Nanopharmaceuticals Consumption by Type
- 6.3 APAC Nanopharmaceuticals Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Nanopharmaceuticals by Countries
- 7.1.1 Europe Nanopharmaceuticals Consumption by Countries (2014-2019)
- 7.1.2 Europe Nanopharmaceuticals Value by Countries (2014-2019)
- 7.2 Europe Nanopharmaceuticals Consumption by Type
- 7.3 Europe Nanopharmaceuticals Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Nanopharmaceuticals by Countries
- 8.1.1 Middle East & Africa Nanopharmaceuticals Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Nanopharmaceuticals Value by Countries (2014-2019)
- 8.2 Middle East & Africa Nanopharmaceuticals Consumption by Type
- 8.3 Middle East & Africa Nanopharmaceuticals Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Nanopharmaceuticals Distributors
- 10.3 Nanopharmaceuticals Customer
11 Global Nanopharmaceuticals Market Forecast
- 11.1 Global Nanopharmaceuticals Consumption Forecast (2019-2024)
- 11.2 Global Nanopharmaceuticals Forecast by Regions
- 11.2.1 Global Nanopharmaceuticals Forecast by Regions (2019-2024)
- 11.2.2 Global Nanopharmaceuticals Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Nanopharmaceuticals Forecast by Type
- 11.8 Global Nanopharmaceuticals Forecast by Application
12 Key Players Analysis
- 12.1 Merck
- 12.1.1 Company Details
- 12.1.2 Nanopharmaceuticals Product Offered
- 12.1.3 Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Merck News
- 12.2 Pfizer
- 12.2.1 Company Details
- 12.2.2 Nanopharmaceuticals Product Offered
- 12.2.3 Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Pfizer News
- 12.3 Novartis
- 12.3.1 Company Details
- 12.3.2 Nanopharmaceuticals Product Offered
- 12.3.3 Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Novartis News
- 12.4 Abbott
- 12.4.1 Company Details
- 12.4.2 Nanopharmaceuticals Product Offered
- 12.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Abbott News
- 12.5 GlaxoSmithKline
- 12.5.1 Company Details
- 12.5.2 Nanopharmaceuticals Product Offered
- 12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 GlaxoSmithKline News
- 12.6 Roche
- 12.6.1 Company Details
- 12.6.2 Nanopharmaceuticals Product Offered
- 12.6.3 Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Roche News
- 12.7 Sanofi
- 12.7.1 Company Details
- 12.7.2 Nanopharmaceuticals Product Offered
- 12.7.3 Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Sanofi News
- 12.8 Eli Lilly
- 12.8.1 Company Details
- 12.8.2 Nanopharmaceuticals Product Offered
- 12.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Eli Lilly News
- 12.9 Astrazeneca
- 12.9.1 Company Details
- 12.9.2 Nanopharmaceuticals Product Offered
- 12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Astrazeneca News
- 12.10 Johnson & Johnson
- 12.10.1 Company Details
- 12.10.2 Nanopharmaceuticals Product Offered
- 12.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Johnson & Johnson News
- 12.11 Celgene
- 12.12 Novavax
- 12.13 Stryker
- 12.14 Gilead Sciences
- 12.15 OSI Pharmaceuticals
- 12.16 Kadmon Pharmaceuticals
- 12.17 Samyang Biopharm
- 12.18 Mitsubishi Pharma
- 12.19 Kaken Pharmaceutical
- 12.20 Selecta Biosciences
- 12.21 Par Pharmaceutical
- 12.22 Cerulean Pharma
- 12.23 Navidea Biopharmaceuticals
- 12.24 Lummy
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Nanopharmaceuticals . Industry analysis & Market Report on Nanopharmaceuticals is a syndicated market report, published as Global Nanopharmaceuticals Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Nanopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
